The abstract is read at the publisher; the summary is JClub's.
Baveno VIII consensus updated guidance for advanced chronic liver disease and portal hypertension, with 272 statements and recommendations reaching strong consensus (>80% agreement).
- Why it matters: The field needed an evidence-based update since Baveno VII to refine risk stratification around CSPH and improve prevention and management of decompensation.
- What they did: An expert faculty, convened by Baveno Cooperation with VALDIG, reviewed post–Baveno VII evidence across nine panels using iterative evidence review and faculty voting.
- The result: The updated guidance reaffirms CSPH and non-invasive testing, revises several diagnostic and prognostic cut-offs, adds selected paediatric recommendations, and proposes a research agenda with 153 priority topics.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- 1 cited this week
- Open access